GIKLY Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 15:52):

Stats
Today's Volume	76.00
Average Volume	4 101.00
Market Cap	5.58B
EPS	$0 ( 2023-09-30 )
Last Dividend	$0.222 ( 2021-06-03 )
Next Dividend	$0 ( N/A )
P/E	88.00
ATR14	$0 (0.00%)

Grifols, S.A. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Grifols, S.A. Financials

Annual	2023
Revenue:	$6.59B
Gross Profit:	$2.32B (35.24 %)
EPS:	$0.0873

Q4	2023
Revenue:	$1.77B
Gross Profit:	$689.83M (38.98 %)
EPS:	$0.0825

Q3	2023
Revenue:	$1.60B
Gross Profit:	$631.83M (39.55 %)
EPS:	$0.0439

Q2	2023
Revenue:	$1.66B
Gross Profit:	$620.06M (37.28 %)
EPS:	$0.0767

Financial Reports:

No articles found.

Grifols, S.A. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Grifols, S.A. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 5.87 - average (62.70%) | Divividend Growth Potential Score: 2.54 - No dividend growth expected in the near future

Information

First Dividend	$0.0385	2010-06-28
Last Dividend	$0.222	2021-06-03
Next Dividend	$0	N/A
Payout Date	2021-06-14
Next Payout Date	N/A
# dividends	16	--
Total Paid Out	$1.516	--
Avg. Dividend % Per Year	0.00%	--
Score	1.92	--
Div. Sustainability Score	5.87
Div.Growth Potential Score	2.54
Div. Directional Score	4.20	--

Next Divdend (Est)
(2024-06-20)

$0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.92

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
TSRYY	Ex Dividend Knight	2023-08-30	Semi-Annually	0.00%
JMSB	Ex Dividend Junior	2023-06-26	Annually	0.00%
BOSSY	Ex Dividend Junior	2023-05-10	Annually	0.00%
REPYY	Ex Dividend Knight	2023-07-03	Annually	0.00%
FBTT	Ex Dividend Knight	2023-09-21	Quarterly	0.00%
VNRFY	Ex Dividend Junior	2023-05-30	Annually	0.00%
LNVGY	Ex Dividend Knight	2023-07-26	Annually	0.00%
CKHUY	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
SGAPY	Ex Dividend Knight	2023-08-02	Semi-Annually	0.00%
GNGBY	Ex Dividend Junior	2023-04-27	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0251	1.500	9.50	10.00	[0 - 0.5]
returnOnAssetsTTM	0.00769	1.200	9.74	10.00	[0 - 0.3]
returnOnEquityTTM	0.0279	1.500	-0.801	-1.202	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.79	0.800	1.069	0.855	[1 - 3]
quickRatioTTM	0.629	0.800	-1.005	-0.804	[0.8 - 2.5]
cashRatioTTM	0.229	1.500	9.84	10.00	[0.2 - 2]
debtRatioTTM	0.425	-1.500	2.92	-4.38	[0 - 0.6]
interestCoverageTTM	2.02	1.000	-0.363	-0.363	[3 - 30]
operatingCashFlowPerShareTTM	0.307	2.00	9.90	10.00	[0 - 30]
freeCashFlowPerShareTTM	-0.0538	2.00	-0.0269	-0.0538	[0 - 20]
debtEquityRatioTTM	1.564	-1.500	3.74	-5.62	[0 - 2.5]
grossProfitMarginTTM	0.381	1.000	6.99	6.99	[0.2 - 0.8]
operatingProfitMarginTTM	0.135	1.000	9.30	9.30	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0229	1.000	-0.984	-0.984	[0.2 - 2]
assetTurnoverTTM	0.306	0.800	-1.291	-1.033	[0.5 - 2]
Total Score				5.87

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	16.91	1.000	8.39	0	[1 - 100]
returnOnEquityTTM	0.0279	2.50	-0.515	-1.202	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.0538	2.00	-0.0179	-0.0538	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.307	2.00	9.90	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.805	1.500	7.97	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0317	1.000	-1.708	0	[0.1 - 0.5]
Total Score				2.54

Grifols, S.A.

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuumfrom prevention, screening, diagnosis, and prognosis to disease and treatment monitoringto serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.